STAT+: Eli Lilly diabetes drug Mounjaro in short supply, FDA says
The U.S. Food and Drug Administration has declared a shortage of Eli Lilly’s Mounjaro, the latest diabetes drug to be in short supply.
Due to increased demand for the medication, pharmacies may experience delays in receiving full shipments of the 5-milligram dose through January, according to a posting this week on the regulator’s website.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Eli Lilly diabetes drug Mounjaro in short supply, FDA says »
